COVID-19 mRNA-1273 vaccine induces production of vaccine-induced immune thrombotic thrombocytopenia antibodies.
Published in American journal of hematology
COVID-19 mRNA-1273 vaccine induces production of vaccine-induced immune thrombotic thrombocytopenia antibodies.
Blood exchange transfusion with dexamethasone and Tocilizumab for management of hospitalized patients with sickle cell d...
...
Published in American Journal of Hematology
Clinical predictors of COVID ‐19 severity and bleeding in the ACTIV‐4B COVID ‐19 outpatient thrombosis prevention trial
Published in American Journal of Hematology
Drug (vaccine)-induced thrombocytopenia 2021: Diversity of pathogenesis and clinical features.
Published in American journal of hematology
COVID-19 vaccine response in patients with hematologic malignancy: A systematic review and meta-analysis.
Published in American journal of hematology
SARS‐CoV ‐2 vaccination in patients with paroxysmal nocturnal hemoglobinuria: An Italian multicenter survey
...
Published in American Journal of Hematology
Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France.
...
Published in American journal of hematology
Heterologous SARS-CoV-2 vaccinations in patients with B-cell lymphoid malignancies.
Published in American journal of hematology
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infec...
...
Published in American journal of hematology
Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS‐CoV ‐2: Results o...
...
Published in American Journal of Hematology
